patrick.net
An Antidote to Corporate Media
1,259,304 comments by 15,036 users - PeopleUnited, SouthMtn online now
Thread for vax deaths, maimings, and severe side effects
invite response
2021 Jul 28, 8:33pm 889,704 views 8,279 comments
« First « Previous Comments 1,537 - 1,576 of 8,279 Next » Last » Search these comments
1542
GNL
2022 Apr 3, 4:49pm
GNL
2022 Apr 3, 4:49pm
Evidently, all 15 players had injuries. Injuries like muscle and ligament type injuries.
1543
porkchopXpress
2022 Apr 3, 7:12pm
porkchopXpress
2022 Apr 3, 7:12pm
WineHorror1 says
Evidently, all 15 players had injuries. Injuries like muscle and ligament type injuries.What is the probability of that happening?
1546
Patrick
2022 Apr 4, 8:06pm
Patrick
2022 Apr 4, 8:06pm
https://www.courier-journal.com/story/news/local/2022/03/18/dr-sarahbeth-hartlage-who-led-louisvilles-covid-vaccine-effort-dies/7090533001/?source=patrick.net
Louisville health department leader who oversaw COVID-19 vaccine distribution has died...
Dr. Sarah Moyer, the city's chief health strategist, called her death "sudden and unexpected."
1547
GNL
2022 Apr 4, 8:32pm
GNL
2022 Apr 4, 8:32pm
Patrick says
I wonder how many jabs she took and how many she made her daughter take?
https://www.courier-journal.com/story/news/local/2022/03/18/dr-sarahbeth-hartlage-who-led-louisvilles-covid-vaccine-effort-dies/7090533001/?source=patrick.net
Louisville health department leader who oversaw COVID-19 vaccine distribution has died...
Dr. Sarah Moyer, the city's chief health strategist, called her death "sudden and unexpected."
I wonder how many jabs she took and how many she made her daughter take?
1549
Al_Sharpton_for_President
2022 Apr 8, 5:02am
Al_Sharpton_for_President
2022 Apr 8, 5:02am
Scandinavia have had fewer Covid restrictions and lower Covid mortality than the rest of Europe. - Martin Kulldorff
1550
AmericanKulak
2022 Apr 8, 1:12pm
AmericanKulak
2022 Apr 8, 1:12pm
Does our fag military still ban beards, while allowing disgusting tattoos and trannies?
1551
Patrick
2022 Apr 8, 5:23pm
Patrick
2022 Apr 8, 5:23pm
https://rairfoundation.com/epidemic-german-and-austrian-mayors-under-60-aresuddenly-and-unexpectedly-dropping-dead/?source=patrick.net
When did so many young and healthy middle-aged people, described as fit and sporty, drop dead before 2020?
Since December 2020, many sudden and unexpected deaths of mayors under 60 years old have occurred in Germany and Austria. Questions are swirling about whether these elected officials were overwhelmed by job stress, or could there be another reason for so many “fit and healthy” politicians dying?
On December 12, 2020, 41-year-old CSU Mayor Dirk Rosenbauer collapsed during a municipal council meeting and later died in a hospital in Coburg. The headline read, “At only 41 years old – mayor from Bavaria collapses during council meeting – dead”.
We are all completely shocked and it is incomprehensible. He was fit and healthy, always walked his dog and played handball
Sadly, the headlines have been filled with similar cases for about two years. The names of Mayors being added to the list of unexpected and sudden deaths seems to be growing steadily.
The “Freie Bremer” channel on Telegram compiled a list of several such incidents, at least 15 known deaths in Germany and Austria in the period mentioned. However, the number of unreported cases could be higher.
December. 12. 2020 41-year-old CSU Mayor Dirk Rosenbauer in Michelau, Germany. He leaves behind a wife and two children.
In September 2020, German Mayor Heinrich Suess died unexpectedly at the age of only 56
In June 2020, the 50-year-old German Mayor of Lenggries, Markus Landthaler, died unexpectedly.
On September 15, 2021, the 47-year-old German Mayor of Limbach-Oberfrohna Jesko Vogel died. He leaves behind a wife and two daughters. From 1991 to 2014, he was a player and captain of the first handball team at BSV Limbach.
October 18, 2021, 57-year-old Deputy Mayor of Kindberg, Peter Sattler, died suddenly on a hike.
On October 21, 2021, the 60-year-old Mayor Christian Ruh of Bodolz on Lake Constance died unexpectedly.
On Saturday, October 24, 2021, Burscheid’s Mayor Stefan Caplan died unexpectedly. He was only 56 years old.
October 28, 2021, 59-year-old German Mayor Wolfgang Eckl “unexpectedly” died.
November 27, 2021, Mayor Jochim Ruppert died unexpectedly on Friday evening at the age of 59.
December 23, 2021, 54-year-old Schiltberg Mayor Fabian Streit died unexpectedly.
March 5, 2022 Mauerkirchen Mayor Horst Gerner died unexpectedly at the age of 57
On March 23, 2022, Mayor Kristian W. Tangermann died unexpectedly. The Mayor of the municipality of Lilienthal (Osterholz district) was only 45 years old.
On March 26, 2022, Christian Maurer, a 38-year-old mayor in Upper Austria, died. He collapsed on March 21 during a municipal council meeting and died days later in the hospital. Doctors could not repair Maurer’s cerebral hemorrhage. The local politician leaves behind his wife and their six-week-old son.
On March 29, 2022, The incumbent Mayor of Waldshut-Tiengen, Joachim Baumert, died unexpectedly over the weekend at the age of 57.
On March 31, The third mayor of Coburg, Thomas Nowak, died suddenly and unexpectedly at the age of 53.
On April 1, 2022, the First Mayor of Pfaffenhausen and trained police officer Franz Renftle died at the age of 54.
1552
Patrick
2022 Apr 8, 8:26pm
Patrick
2022 Apr 8, 8:26pm
https://markcrispinmiller.substack.com/p/in-memory-of-those-who-died-suddenly-b9d?s=r&source=patrick.net
And many more in that article...
Two children dying of heart attacks at school:
'Kind hearted' boy, 12, who died suddenly from heart attack at school is named
March 30, 2022
Ryan Heffernan, 12, was playing with his friends in Shoeburyness High School in Essex when he suddenly collapsed on Monday afternoon as his parents mourn their 'kind-hearted' son
Year 7 student Ryan Heffernan, 12, collapsed on Monday at Shoeburyness High School in Essex.
Essex Police have launched an investigation into his death which they last night described as "unexplained" while ruling out any third-party involvement.
https://www.mirror.co.uk/news/uk-news/kind-hearted-boy-12-who-26590685?source=patrick.net
Heartbreaking tributes to ‘sweetest’ Year 7 boy who collapsed and died of ‘heart attack’ on school field at lunchtime
March 29, 2022
HEARTBREAKING tributes have today been paid to a Year 7 boy who collapsed and died on the school field at lunchtime.
The unnamed youngster tragically passed away at 1:20 pm yesterday after suffering a suspected heart attack at Shoeburyness High School in Essex.
Detectives say they are continuing to investigating the circumstances around his death, which is currently being treated as "unexplained".
https://www.thesun.co.uk/news/18105735/heartbreaking-tributes-boy-collapsed-died-school-field/?source=patrick.net
Three 18-year-olds die of sudden heart conditions:
An 18-year-old died after an ambulance arrived just 'three minutes too late'
April 4, 2022
A 18-year-old who had a 'very good chance' of surviving, tragically died from a cardiac arrest after an ambulance arrived just 'three minutes' too late to save him.
The young man, whose identity is not revealed, suffered the cardiac arrest while out with friends.
He was one of more than 70 people in a year-long period from the West Midlands who might have lived if crews were not 'stacked up' for hours outside hospitals, an ambulance boss claimed last week.
The ambulance service's nursing and commissioning executive director Mark Docherty made the claim just before visiting the teenager's family.
'We were there three minutes too late to save him,' he said.
'He told his friends "I've got a funny feeling" and laid down on the ground, he knew that something was going to happen. And we just didn't get there on time.'
https://www.dailymail.co.uk/news/article-10684555/Tragic-18-year-old-suffered-cardiac-arrest-died-waiting-15-minutes-ambulance.html?source=patrick.net
Loving tributes paid to 'quiet and kind' young goalkeeper, 18, who died suddenly
April 4, 2022
Loving tributes have been paid to a "quiet and kind" young goalkeeper who died suddenly aged 18. Igor Jonczyk passed away on Friday, April 1, after falling ill earlier last month, Denbigh Town FC said.
Igor, originally from Poland, moved to North Wales when he was nine with his two elder brothers, mum Agnieszka and father Artur, and they settled in Ruthin. He passed away surrounded by his family at Wythenshawe Hospital in Manchester.
Described as a "promising and popular member of the football team" with a "flamboyant playing style" Igor was taken to Glan Clwyd hospital on March 3 before being transferred to Manchester where it become apparent that he had been suffering from an underlying heart condition.
https://www.msn.com/en-gb/sport/football/loving-tributes-paid-to-quiet-and-kind-young-goalkeeper-18-who-died-suddenly/ar-AAVPxRz?li=BBoPWjP&source=patrick.net
Tributes paid to Bolton School student Cameron Milton
March 30, 2022
A SCHOOL has led tributes to a student who died in his sleep yesterday.
Cameron Milton died suddenly at the age of just 18 at his home in Edgworth.
Today, flags were flying at half-mast at Bolton School, where the teenager was studying for his A-levels and played for the rugby team.
Head of boys’ division, Nic Ford paid tribute to the popular student.
https://kqeducationgroup.com/tributes-paid-to-bolton-school-student-cameron-milton/?source=patrick.net
And many more in that article...
1553
Ceffer
2022 Apr 9, 12:52am
Ceffer
2022 Apr 9, 12:52am
Another acolyte self immolating on the alter of vaccination before Baphomet:
1554
Al_Sharpton_for_President
2022 Apr 9, 5:03am
Al_Sharpton_for_President
2022 Apr 9, 5:03am
Pfizer Hired 600+ People to Process Vaccine Injury Reports, Documents Reveal
Pfizer hired about 600 additional full-time employees to process adverse event reports during the three months following authorization of its COVID-19 vaccine, with plans to hire 1,800 more by June 2021, newly released documents reveal.
Pfizer hired about 600 additional full-time employees to process adverse event reports during the three months following the Emergency Use Authorization (EUA) of its COVID-19 vaccine, newly released documents reveal.
According to the documents, Pfizer said, “More are joining each month with an expected total of more than 1,800 additional resources by the end of June 2021.”
The information was contained in a 10,000-page document cache released April 1 by the U.S. Food and Drug Administration (FDA) and made public as part of a court-ordered disclosure schedule stemming from an expedited Freedom of Information Act (FOIA) request.
The latest revelations appeared in a document, “Cumulative analysis of post-authorization adverse event reports” of the Pfizer-BioNTech vaccine, highlighting such adverse events identified through Feb. 28, 2021.
The document was previously released in November 2021, but was partially redacted. The redactions included the number of employees Pfizer hired and/or was planning to hire.
According to the unredacted document released April 1:
“Pfizer has also taken a multiple actions [sic] to help alleviate the large increase of adverse event reports. This includes significant technology enhancements, and process and workflow solutions, as well as increasing the number of data entry and case processing colleagues.
“To date, Pfizer has onboarded approximately 600 additional full-time employees (FTEs).
“More are joining each month with an expected total of more than 1,800 additional resources by the end of June 2021.”
The unredacted version also revealed the number of Pfizer-BioNTech vaccine doses shipped worldwide between December 2020 and February 2021:
“It is estimated that approximately 126,212,580 doses of BNT162b2 [the Pfizer EUA vaccine] were shipped worldwide from the receipt of the first temporary authorisation for emergency supply on 01 December 2020 through 28 February 2021.”
The number of shipped doses previously was redacted.
Remarking upon this newly revealed information, Brian Hooker, chief scientific officer of Children’s Health Defense, told The Defender:
“The rollout of the Pfizer vaccine has led to an unprecedented number of adverse events reported — 158,000 adverse events in the first two-plus months of the rollout means that the rate of reported AE [adverse events] was approximately 1:1000, with many of the AEs graded as serious. This is based on a denominator of 125,000,000 vaccines distributed.
“It is no wonder that an army of 1,800 individuals was needed to process all of the information.”
Hooker noted the total number (1,205,755) of COVID vaccine adverse events reported to the Vaccine Adverse Event Reporting System between Dec. 14, 2020 and March 25, 2022, now eclipses the total number (930,952) of adverse events reported in the 32-year history of the database.
Dr. Madhava Setty, a board-certified anesthesiologist and senior science editor for The Defender, previously reported on the same Pfizer document, before the unredacted version was released.
“In that piece, I alluded to Pfizer’s admission that they needed more staff to process all of the adverse events being reported to them,” Setty said.
“It seems this document has now been updated. 600 FTEs [full-time employees]! … I wonder how many extra people the CDC [U.S. Centers for Disease Control and Protection] has hired? Given how they are operating, I would say zero.”
Pfizer downplayed adverse reactions in request for full FDA license
The April 1 document release also included “request for priority review” — the documentation Pfizer in May 2021 submitted to the FDA for full licensure of its Comirnaty COVID vaccine.
In this document, Pfizer described its vaccine as fulfilling an “unmet medical need,” claiming:
“Mass immunization with a safe and effective vaccine against COVID-19 can dramatically alter the trajectory of the pandemic.
“According to policy briefing by the Institute for Health Metrics and Evaluation published on 31 March 2021, COVID-19 remains a leading cause of death in the US with up to 100,000 additional deaths projected in the US between March and July 2021, many of which can likely be prevented with COVID-19 vaccination.”
Pfizer expressed “concerns” about lifting COVID-related measures, such as lockdowns, on the basis that the lifting of such restrictions would “counteract the impacts of this vaccination effort.”
The document states:
“Vaccination against COVID-19 began with EUA/conditional approvals in December 2020, in a phased rollout defined by national/regional guidance.
“However, there continue to be concerning trends that may counteract the impacts of this vaccination effort, including:
“[L]imitations in access to obtaining a vaccine due to infrastructure challenges (ie, clinic and appointment capacity and systems)
“[I]ncreasing viral transmission fueled by relaxed compliance with mitigations as the pandemic surpasses the 1-year mark (ie, masks, physical distancing, limiting travel)
“[I]ncreasing circulation of emerging variants of concern (which are currently driving continued spread of viral infection in Europe despite extensive mitigation mandates).”
Pfizer justified its request for full licensure of its COVID vaccine on the following basis:
“A vaccine program must be implemented expediently and rapidly expanded to have a significant impact on the pandemic course.
“Licensure of BNT162b2 is likely to enhance vaccine uptake by facilitating supply of vaccine from Pfizer/BioNTech directly to pharmacies and healthcare providers/facilities.
“The greatest impact of BNT162b2 licensure may be direct supply to healthcare providers who serve vulnerable populations such as elderly patients and those who live in rural and underserved communities (ie, individuals who might be unable to navigate the challenges of securing vaccine access using the systems in place for EUA).
“Expansion of vaccine via licensure would ultimately improve the prospect of achieving population herd immunity to bring the pandemic under control.”
The same document glossed over the adverse effects for which the company previously admitted it hired a significant number of new employees to process, claiming:
“Based on Phase 1 data from the FIH Study BNT162-01, BNT162b1 and BNT162b2 [various vaccines tested during the trial period] were safe and well-tolerated in healthy adults 18 to 55 years of age, with no unanticipated safety findings.
“Phase 2/3 safety data were generally concordant with safety data in Phase 1 of the study, both overall and with regard to younger and older participants.”
This is despite hard figures regarding adverse reactions provided later in the document:
“Through 28 February 2021 (data lock point aligned with Pharmacovigilance Plan), there were a total of 42,086 case reports (25,379 medically confirmed and 16,707 non-medically confirmed) containing 158,893 events. Cases were received from 63 countries.
“Consistent with what was seen in Phase 2/3 of Study C4591001, most reported AEs were in System Organ Classes (SOCs) with reactogenicity events: general disorders and administration site conditions (51,335), nervous system disorders (25,957), musculoskeletal and connective tissue disorders (17,283), and gastrointestinal disorders (14,096).
“Post-authorization data have also informed the addition of adverse drug reactions (ADRs) related to the experience of reactogenicity to the product labeling.”
Release of Pfizer vaccine documents still in progress
Many of the documents released as part of the April 1 tranche appear to include more mundane information and data related to the Pfizer COVID vaccine trials.
These documents include:
Peer-reviewed scientific articles funded by Pfizer-BioNTech, titled “Phase 1/2 Study of COVID-19 RNA Vaccine” (August 2020) and “Safety and Immunogenicity of Two RANA-Based Covid-19 Vaccine Candidates,” published in the New England Journal of Medicine in October 2020. These studies supported “further evaluation of this mRNA vaccine candidate” despite the apparent appearance of serious adverse effects in one of the 12 participants receiving 30 μg and 100 μg doses of the BNT162b1 candidate vaccine during the trial phase. This, however, does not appear to have been the final vaccine formulation that ultimately received an EUA.
A questionnaire that vaccine trial participants were required to complete, along with a study book displaying the information to be collected from those participating.
Documents outlining the randomization scheme used for identifying vaccine trial participants and those who received doses of the vaccine or a placebo.
Documents listing anonymized demographic characteristics of vaccine trial participants.
An anonymized listing of important protocol deviations.
Consent forms that vaccine trial participants were asked to complete, as well as other related documents submitted by Pfizer for Institutional Review Board (IRB) approval, and information regarding institutions participating in the IRB process.
Clinical study approval forms.
Audit certificates for vaccine trial locations.
The next set of documents — an expected 80,000 pages — is scheduled to be released on or before May 1.
https://childrenshealthdefense.org/defender/pfizer-hired-600-people-vaccine-injury-reports/?source=patrick.net
Pfizer hired about 600 additional full-time employees to process adverse event reports during the three months following authorization of its COVID-19 vaccine, with plans to hire 1,800 more by June 2021, newly released documents reveal.
Pfizer hired about 600 additional full-time employees to process adverse event reports during the three months following the Emergency Use Authorization (EUA) of its COVID-19 vaccine, newly released documents reveal.
According to the documents, Pfizer said, “More are joining each month with an expected total of more than 1,800 additional resources by the end of June 2021.”
The information was contained in a 10,000-page document cache released April 1 by the U.S. Food and Drug Administration (FDA) and made public as part of a court-ordered disclosure schedule stemming from an expedited Freedom of Information Act (FOIA) request.
The latest revelations appeared in a document, “Cumulative analysis of post-authorization adverse event reports” of the Pfizer-BioNTech vaccine, highlighting such adverse events identified through Feb. 28, 2021.
The document was previously released in November 2021, but was partially redacted. The redactions included the number of employees Pfizer hired and/or was planning to hire.
According to the unredacted document released April 1:
“Pfizer has also taken a multiple actions [sic] to help alleviate the large increase of adverse event reports. This includes significant technology enhancements, and process and workflow solutions, as well as increasing the number of data entry and case processing colleagues.
“To date, Pfizer has onboarded approximately 600 additional full-time employees (FTEs).
“More are joining each month with an expected total of more than 1,800 additional resources by the end of June 2021.”
The unredacted version also revealed the number of Pfizer-BioNTech vaccine doses shipped worldwide between December 2020 and February 2021:
“It is estimated that approximately 126,212,580 doses of BNT162b2 [the Pfizer EUA vaccine] were shipped worldwide from the receipt of the first temporary authorisation for emergency supply on 01 December 2020 through 28 February 2021.”
The number of shipped doses previously was redacted.
Remarking upon this newly revealed information, Brian Hooker, chief scientific officer of Children’s Health Defense, told The Defender:
“The rollout of the Pfizer vaccine has led to an unprecedented number of adverse events reported — 158,000 adverse events in the first two-plus months of the rollout means that the rate of reported AE [adverse events] was approximately 1:1000, with many of the AEs graded as serious. This is based on a denominator of 125,000,000 vaccines distributed.
“It is no wonder that an army of 1,800 individuals was needed to process all of the information.”
Hooker noted the total number (1,205,755) of COVID vaccine adverse events reported to the Vaccine Adverse Event Reporting System between Dec. 14, 2020 and March 25, 2022, now eclipses the total number (930,952) of adverse events reported in the 32-year history of the database.
Dr. Madhava Setty, a board-certified anesthesiologist and senior science editor for The Defender, previously reported on the same Pfizer document, before the unredacted version was released.
“In that piece, I alluded to Pfizer’s admission that they needed more staff to process all of the adverse events being reported to them,” Setty said.
“It seems this document has now been updated. 600 FTEs [full-time employees]! … I wonder how many extra people the CDC [U.S. Centers for Disease Control and Protection] has hired? Given how they are operating, I would say zero.”
Pfizer downplayed adverse reactions in request for full FDA license
The April 1 document release also included “request for priority review” — the documentation Pfizer in May 2021 submitted to the FDA for full licensure of its Comirnaty COVID vaccine.
In this document, Pfizer described its vaccine as fulfilling an “unmet medical need,” claiming:
“Mass immunization with a safe and effective vaccine against COVID-19 can dramatically alter the trajectory of the pandemic.
“According to policy briefing by the Institute for Health Metrics and Evaluation published on 31 March 2021, COVID-19 remains a leading cause of death in the US with up to 100,000 additional deaths projected in the US between March and July 2021, many of which can likely be prevented with COVID-19 vaccination.”
Pfizer expressed “concerns” about lifting COVID-related measures, such as lockdowns, on the basis that the lifting of such restrictions would “counteract the impacts of this vaccination effort.”
The document states:
“Vaccination against COVID-19 began with EUA/conditional approvals in December 2020, in a phased rollout defined by national/regional guidance.
“However, there continue to be concerning trends that may counteract the impacts of this vaccination effort, including:
“[L]imitations in access to obtaining a vaccine due to infrastructure challenges (ie, clinic and appointment capacity and systems)
“[I]ncreasing viral transmission fueled by relaxed compliance with mitigations as the pandemic surpasses the 1-year mark (ie, masks, physical distancing, limiting travel)
“[I]ncreasing circulation of emerging variants of concern (which are currently driving continued spread of viral infection in Europe despite extensive mitigation mandates).”
Pfizer justified its request for full licensure of its COVID vaccine on the following basis:
“A vaccine program must be implemented expediently and rapidly expanded to have a significant impact on the pandemic course.
“Licensure of BNT162b2 is likely to enhance vaccine uptake by facilitating supply of vaccine from Pfizer/BioNTech directly to pharmacies and healthcare providers/facilities.
“The greatest impact of BNT162b2 licensure may be direct supply to healthcare providers who serve vulnerable populations such as elderly patients and those who live in rural and underserved communities (ie, individuals who might be unable to navigate the challenges of securing vaccine access using the systems in place for EUA).
“Expansion of vaccine via licensure would ultimately improve the prospect of achieving population herd immunity to bring the pandemic under control.”
The same document glossed over the adverse effects for which the company previously admitted it hired a significant number of new employees to process, claiming:
“Based on Phase 1 data from the FIH Study BNT162-01, BNT162b1 and BNT162b2 [various vaccines tested during the trial period] were safe and well-tolerated in healthy adults 18 to 55 years of age, with no unanticipated safety findings.
“Phase 2/3 safety data were generally concordant with safety data in Phase 1 of the study, both overall and with regard to younger and older participants.”
This is despite hard figures regarding adverse reactions provided later in the document:
“Through 28 February 2021 (data lock point aligned with Pharmacovigilance Plan), there were a total of 42,086 case reports (25,379 medically confirmed and 16,707 non-medically confirmed) containing 158,893 events. Cases were received from 63 countries.
“Consistent with what was seen in Phase 2/3 of Study C4591001, most reported AEs were in System Organ Classes (SOCs) with reactogenicity events: general disorders and administration site conditions (51,335), nervous system disorders (25,957), musculoskeletal and connective tissue disorders (17,283), and gastrointestinal disorders (14,096).
“Post-authorization data have also informed the addition of adverse drug reactions (ADRs) related to the experience of reactogenicity to the product labeling.”
Release of Pfizer vaccine documents still in progress
Many of the documents released as part of the April 1 tranche appear to include more mundane information and data related to the Pfizer COVID vaccine trials.
These documents include:
Peer-reviewed scientific articles funded by Pfizer-BioNTech, titled “Phase 1/2 Study of COVID-19 RNA Vaccine” (August 2020) and “Safety and Immunogenicity of Two RANA-Based Covid-19 Vaccine Candidates,” published in the New England Journal of Medicine in October 2020. These studies supported “further evaluation of this mRNA vaccine candidate” despite the apparent appearance of serious adverse effects in one of the 12 participants receiving 30 μg and 100 μg doses of the BNT162b1 candidate vaccine during the trial phase. This, however, does not appear to have been the final vaccine formulation that ultimately received an EUA.
A questionnaire that vaccine trial participants were required to complete, along with a study book displaying the information to be collected from those participating.
Documents outlining the randomization scheme used for identifying vaccine trial participants and those who received doses of the vaccine or a placebo.
Documents listing anonymized demographic characteristics of vaccine trial participants.
An anonymized listing of important protocol deviations.
Consent forms that vaccine trial participants were asked to complete, as well as other related documents submitted by Pfizer for Institutional Review Board (IRB) approval, and information regarding institutions participating in the IRB process.
Clinical study approval forms.
Audit certificates for vaccine trial locations.
The next set of documents — an expected 80,000 pages — is scheduled to be released on or before May 1.
https://childrenshealthdefense.org/defender/pfizer-hired-600-people-vaccine-injury-reports/?source=patrick.net
1556
Al_Sharpton_for_President
2022 Apr 9, 1:50pm
Al_Sharpton_for_President
2022 Apr 9, 1:50pm
Vaccinated Have Up To SIX Times the Infection Rate of Unvaccinated, New Zealand Government Data Show
New Zealand is a fascinating country – amazing geography, likeable population, and, unlike its neighbour Australia, most of its wildlife isn’t planning on killing you at the slightest opportunity. It is also fascinating with respect to Covid because its population has a very high vaccination rate across all age groups (well, down to five), but up until recently there has been negligible natural immunity to Covid. Because of these two factors, New Zealand was always going to be of interest as soon as Covid arrived properly, if only to see how its vaccination efforts had protected its population.
For those who missed it, since the end of last year New Zealand has had a succession of Covid waves. These started small, but in the most recent wave, taking place during February and March, infection rates were enormous – if we had these infection rates in the U.K. we’d have peaked at approximately 350,000 cases per day (rather than around 200,000). What’s more, it looks like New Zealand exceeded its testing capacity during that wave, suggesting that peak infections were probably even higher. It is relevant to note that during February and March, New Zealand had over 90% of all the cases it has ever had and most of the rest occurred in January – prior to 2022 New Zealand reported very few Covid infections.
So much for the Covid vaccines protecting against infection – but what do the data look like in detail?
Cases
New Zealand is somewhat helpful in that it does publish daily cases, hospitalisations and deaths by vaccine status; somewhat because it doesn’t allow easy access to anything other than the current day’s report. Thankfully, the Wayback Machine ensures that at least some web pages aren’t forever lost to history. These data were collated for dates since mid February 2022 and smoothed with a seven-day moving average to create a time series of Covid cases by vaccine status.
The first time the above graph popped up on my computer screen I had to go and double check all the data sources – and then I triple checked them. The data shown on the graph are notable for several reasons:
Firstly the obvious one – during the most recent Covid wave there was a much lower infection rate in the unvaccinated, compared with those that had been given one, two or three doses of vaccine. What’s more, this isn’t a small effect – over the period shown approximately:
10% of the triple vaccinated in New Zealand were infected.
14% of the single vaccinated were infected.
An astounding 18% of the double vaccinated were infected.
Yet only 3% of the unvaccinated appear to have been infected.
The order of the effect is unexpected – for some time in the U.K. the highest case rates have been found in the triple vaccinated, with case rates in the single and double jabbed much lower. In New Zealand the highest rates are seen in the double vaccinated.
The data for cases in the double dosed appear to have an earlier peak than seen in the data for the unvaccinated, single jabbed and triple jabbed.
The fall from peak cases to the most recent data point is also interesting. Case rates in the unvaccinated, single dosed and the double dosed have all fallen approximately 45% since their respective peaks, however, case rates in the triple vaccinated have only fallen approximately 20% since their peak. This is rather concerning, as it suggests that we might find that the boosted population maintain a viral reservoir for Covid, ensuring that case rates take much longer to fall to trivial levels and hindering attempts to get society back to a post-Covid normal.
The infections data from New Zealand allow us to estimate the vaccine effectiveness for the Covid vaccines in the absence of natural immunity.
Unadjusted estimates of vaccine effectiveness against infection as at end of March 2022
These data are in contrast to recent data from the U.K., which show one and two doses of vaccine to have a VE of minus-50% to minus-100%, and the booster to have a VE of around minus-300%. While this sounds counterintuitive, it is possible that we’re seeing a complex interplay between a waning of the impact of the vaccine and the impact of additional vaccine doses:
The U.K. vaccinated early, allowing for the impact of those early vaccine doses to have waned significantly for those choosing not to top-up their ‘protection’.
The Covid vaccines appear to have a period of approximately two to three months where their impact on the immune system is different than in later periods; this is possibly due to the creation of short-lived IgA (mucosal) antibodies. In the U.K., booster vaccinations were given in autumn 2021, and thus most individuals will have been beyond this period when the Omicron variant’s first wave appeared in December.
In New Zealand, the timescales are very different: those given the booster dose will still be in the two-three month period where short-lived immune responses dominate; those given two doses will be in the proposed period of maximal vaccine negative impact; while those that chose not to accept the offer of a second vaccine dose will be in the period where vaccine effects are waning.
There’s one more point to add for cases in New Zealand, and it relates to the U.K. For months, the UKHSA has been telling us that one possible reason for us seeing far fewer cases in the unvaccinated compared with the vaccinated is because the unvaccinated have natural immunity following high infection rates previously (presumably because the unvaccinated are reckless and didn’t follow lockdown rules – I imagine that they also ride motorcycles too quickly, set off fireworks indoors and play with matches while filling up the car). These data from New Zealand, which at the time had very few individuals previously infected with Covid, show lower case rates in the unvaccinated without any significant levels of natural immunity, contradicting the claim of the UKHSA and eliminating one of its reasons for ignoring the alarming data.
Hospitalisations
Analysis of the hospitalisations data offered by the New Zealand authorities is made complex by there being no stratification of the hospitalisations by age group, and the lack of complete vaccinations data by age. However, U.K. data show that in recent weeks approximately 95% of hospitalisations were in those aged over 60; assuming that this will also hold true for the New Zealand population allows us to offer a indicative analysis of the likely impact for that age group of the vaccines on hospitalisations in the country.
The analysis is also hindered by the data on vaccine coverage for those aged over 60 not differentiating between those that have had only one dose of vaccine and those that are unvaccinated. This might in isolation from other data appear to be ‘sensible’ – after all, the single dosed have the ‘least protection’ as well as ‘the longest time for protection to wane’. However, the data shown in the previous section suggest that the unvaccinated and those having taken a single dose of vaccine are in no way comparable, and that considering them as a single group could lead to misleading conclusions. Nevertheless, that’s the hand that’s been dealt for us.
The data are somewhat surprising. While those given a booster dose of vaccine seem to have lower levels of hospitalisations than found in the group containing the unvaccinated and those given only one dose of vaccine – as might be expected – the double dosed have significantly higher hospitalisation rates.
Also interesting is the trend in the data:
Hospitalisations in the unvaccinated/single-dosed appear to peak earliest – we have also seen this effect in U.K. data, usually in the form of dire warnings early in each Covid wave that the only people being hospitalised are the unvaccinated, only for the warnings to go quiet later in the Covid wave when the data move in the opposite direction.
Hospitalisations in those given two doses of vaccine appear to peak towards the end of the period shown.
Hospitalisations in the boosted population appear to show little signs of slowing down, let alone reducing, over the period in question. Note also that this group saw a fourfold increase over the time period shown, whereas the double dose and single-dose/unvaccinated group both saw a 25% increase, albeit with an intermediate period with higher hospitalisation rates.
It was not possible to properly disentangle the hospitalisations data for the unvaccinated, but the data suggest that in aggregate those having taken two or three doses of vaccine (when the two groups are put together) have approximately 45% lower risk of hospitalisation than the unvaccinated/single-dosed. It is worth noting that in the U.K. data we see higher hospitalisation rates in the single vaccinated in those aged over 60, compared with the unvaccinated. It is possible that the same pattern is found in New Zealand, only ‘covered up’ by the co-mingling of the data. If this is the case then the apparent protection offered by the vaccine in the two or three dose individuals will be somewhat lower than 45%.
Deaths
The mortality data from New Zealand are also complicated because the health authorities lump together into one group all the unvaccinated and those having taken a single dose of vaccine. Beyond that complication, deaths data can be tricky to analyse, because there are such huge differences in death rates from (or with) Covid by age. Fortunately, the mortality data offered by the New Zealand authorities do include deaths by age group, which allows a finer analysis than was possible with the infections and hospitalisations data.
Covid mortality per 100,000 per week, by vaccination status and age
The above table suggests that while those given three doses of vaccine have a decreased risk of death from (or with) Covid compared with the mortality rate in the strange group called ‘unvaccinated or one dose’, the risk of death is greatest in those given two doses of vaccine.
However, it is possible that New Zealand’s data have a similar pattern to that seen in the U.K. (and elsewhere), where dose effects are complicated by the health of those given each vaccine, namely that those closest to death were spared a dose of vaccine, and thus concentrated deaths into the very small number left in the prior dose group. A comparison of the data for ‘unvaccinated or one dose’ with ‘two or three doses’ suggests that the vaccines do still protect against death, but only to a very low degree in younger age groups.
Covid mortality per 100,000 per week, by vaccination status and age
The data above support the use of vaccination to protect against death from (or with) Covid for those aged over 80. On the other hand, the mortality rate in those aged under 60 is very low, and the estimated vaccine effectiveness in protecting against death for those aged under 80 is only approximately 30% – once again, the real-world vaccine effectiveness estimate is rather low. It is also of note that these rather poor figures for the protection offered by the vaccines against mortality come from a country that started vaccination rather late (summer 2021) and where most of the population were only given their booster doses two to three months ago. These data suggest that the vaccines simply do not offer substantive protection against death for newer Covid variants, rather than it simply being a case of waning vaccine protection.
It is also important to note that the data on the benefits of the vaccine in protecting against death shown above should be treated with caution:
Data on deaths in the unvaccinated and those given a single dose of vaccine are co-mingled; the New Zealand hospitalisation data suggest that death rates might be greater in the single-jabbed.
The vaccinated appear to have significant increased risk of catching Covid, which contributes to overall risk of serious disease and death.
These calculations do not include any consideration of the risk of side-effects and complications following vaccination.
Overall mortality
One other aspect of the data coming from New Zealand that is of interest relating to Covid is excess mortality. These data are of interest because New Zealand managed to keep itself more-or-less clear of Covid until the last few months of 2021, and even then case numbers were very low until 2022, with the result that Covid deaths were negligible prior to 2022. With that in mind, its excess death data between the start of 2020 and the end of 2021 are very interesting.
Many countries around the world had a peak in excess deaths in the first quarter of 2020, followed by a significant reduction in deaths into mid 2020. There has been speculation that this pattern was seen because Covid infections in early 2020 killed the most vulnerable, leaving a period in which there were fewer people left to die. However, New Zealand also has this pattern of excess deaths in the first half of 2020 (black data points in the graph above) without Covid infections, suggesting that the reduction in deaths seen in mid 2020 were a result of lockdown. The reason for the excess deaths in New Zealand in the first quarter of 2020 are not at all clear.
Most countries then saw an increase in deaths towards the end of 2020; this has been explained by a resurgence in Covid cases. However, New Zealand saw a similar pattern without Covid infections (red data points). It is possible that this increase was caused by the impact of the reduced healthcare provision during the extreme lockdown – though there are no data to support this supposition. There are reports that the New Zealand healthcare system experienced its busiest summer (January and February) on record with hospitals across the country reaching ‘crisis point’ and several emergency departments at capacity. The cause of this healthcare pressure is unclear, however.
Perhaps the most interesting data in the graph above are seen in 2021. During the first half of 2021 excess deaths slowly reduced from the high seen at the start of 2021 (green data points), perhaps a result of healthcare provision returning to normal. However, around mid-year the trend reversed and excess deaths started to climb again (purple data points). Again, it must be pointed out that there were very few Covid cases in New Zealand at this time, and negligible deaths. Just about the only unusual things occurring in the country at that time were a lack of international travel, restrictions in day-to-day activities for the population and an enormous mass vaccination campaign using novel, under-tested vaccines.
During 2020-2022, there were approximately 2,000 excess deaths in New Zealand, a significant number in a country with a population of five million. We don’t know the proportion that occurred because of lockdown, vaccines or something else; all that we do know is that they weren’t a result of Covid.
Note on data analysis methods. Infection, hospitalisation and mortality data were obtained from the New Zealand Ministry for Health (using Wayback Machine for historical data). Vaccination data were also obtained from the NZ Ministry for Health. Population data were obtained from Stats.govt.nz. Vaccination data were offset by seven days for the infections analysis to account for the Ministry for Health’s definition of vaccine status at infection. An additional seven days offset was applied for hospitalisation, and 14 days for death, to account for the typical timescales of disease progression.
https://dailysceptic.org/2022/04/09/vaccinated-have-up-to-six-times-the-infection-rate-of-unvaccinated-new-zealand-government-data-show/?source=patrick.net
New Zealand is a fascinating country – amazing geography, likeable population, and, unlike its neighbour Australia, most of its wildlife isn’t planning on killing you at the slightest opportunity. It is also fascinating with respect to Covid because its population has a very high vaccination rate across all age groups (well, down to five), but up until recently there has been negligible natural immunity to Covid. Because of these two factors, New Zealand was always going to be of interest as soon as Covid arrived properly, if only to see how its vaccination efforts had protected its population.
For those who missed it, since the end of last year New Zealand has had a succession of Covid waves. These started small, but in the most recent wave, taking place during February and March, infection rates were enormous – if we had these infection rates in the U.K. we’d have peaked at approximately 350,000 cases per day (rather than around 200,000). What’s more, it looks like New Zealand exceeded its testing capacity during that wave, suggesting that peak infections were probably even higher. It is relevant to note that during February and March, New Zealand had over 90% of all the cases it has ever had and most of the rest occurred in January – prior to 2022 New Zealand reported very few Covid infections.
So much for the Covid vaccines protecting against infection – but what do the data look like in detail?
Cases
New Zealand is somewhat helpful in that it does publish daily cases, hospitalisations and deaths by vaccine status; somewhat because it doesn’t allow easy access to anything other than the current day’s report. Thankfully, the Wayback Machine ensures that at least some web pages aren’t forever lost to history. These data were collated for dates since mid February 2022 and smoothed with a seven-day moving average to create a time series of Covid cases by vaccine status.
The first time the above graph popped up on my computer screen I had to go and double check all the data sources – and then I triple checked them. The data shown on the graph are notable for several reasons:
Firstly the obvious one – during the most recent Covid wave there was a much lower infection rate in the unvaccinated, compared with those that had been given one, two or three doses of vaccine. What’s more, this isn’t a small effect – over the period shown approximately:
10% of the triple vaccinated in New Zealand were infected.
14% of the single vaccinated were infected.
An astounding 18% of the double vaccinated were infected.
Yet only 3% of the unvaccinated appear to have been infected.
The order of the effect is unexpected – for some time in the U.K. the highest case rates have been found in the triple vaccinated, with case rates in the single and double jabbed much lower. In New Zealand the highest rates are seen in the double vaccinated.
The data for cases in the double dosed appear to have an earlier peak than seen in the data for the unvaccinated, single jabbed and triple jabbed.
The fall from peak cases to the most recent data point is also interesting. Case rates in the unvaccinated, single dosed and the double dosed have all fallen approximately 45% since their respective peaks, however, case rates in the triple vaccinated have only fallen approximately 20% since their peak. This is rather concerning, as it suggests that we might find that the boosted population maintain a viral reservoir for Covid, ensuring that case rates take much longer to fall to trivial levels and hindering attempts to get society back to a post-Covid normal.
The infections data from New Zealand allow us to estimate the vaccine effectiveness for the Covid vaccines in the absence of natural immunity.
Unadjusted estimates of vaccine effectiveness against infection as at end of March 2022
These data are in contrast to recent data from the U.K., which show one and two doses of vaccine to have a VE of minus-50% to minus-100%, and the booster to have a VE of around minus-300%. While this sounds counterintuitive, it is possible that we’re seeing a complex interplay between a waning of the impact of the vaccine and the impact of additional vaccine doses:
The U.K. vaccinated early, allowing for the impact of those early vaccine doses to have waned significantly for those choosing not to top-up their ‘protection’.
The Covid vaccines appear to have a period of approximately two to three months where their impact on the immune system is different than in later periods; this is possibly due to the creation of short-lived IgA (mucosal) antibodies. In the U.K., booster vaccinations were given in autumn 2021, and thus most individuals will have been beyond this period when the Omicron variant’s first wave appeared in December.
In New Zealand, the timescales are very different: those given the booster dose will still be in the two-three month period where short-lived immune responses dominate; those given two doses will be in the proposed period of maximal vaccine negative impact; while those that chose not to accept the offer of a second vaccine dose will be in the period where vaccine effects are waning.
There’s one more point to add for cases in New Zealand, and it relates to the U.K. For months, the UKHSA has been telling us that one possible reason for us seeing far fewer cases in the unvaccinated compared with the vaccinated is because the unvaccinated have natural immunity following high infection rates previously (presumably because the unvaccinated are reckless and didn’t follow lockdown rules – I imagine that they also ride motorcycles too quickly, set off fireworks indoors and play with matches while filling up the car). These data from New Zealand, which at the time had very few individuals previously infected with Covid, show lower case rates in the unvaccinated without any significant levels of natural immunity, contradicting the claim of the UKHSA and eliminating one of its reasons for ignoring the alarming data.
Hospitalisations
Analysis of the hospitalisations data offered by the New Zealand authorities is made complex by there being no stratification of the hospitalisations by age group, and the lack of complete vaccinations data by age. However, U.K. data show that in recent weeks approximately 95% of hospitalisations were in those aged over 60; assuming that this will also hold true for the New Zealand population allows us to offer a indicative analysis of the likely impact for that age group of the vaccines on hospitalisations in the country.
The analysis is also hindered by the data on vaccine coverage for those aged over 60 not differentiating between those that have had only one dose of vaccine and those that are unvaccinated. This might in isolation from other data appear to be ‘sensible’ – after all, the single dosed have the ‘least protection’ as well as ‘the longest time for protection to wane’. However, the data shown in the previous section suggest that the unvaccinated and those having taken a single dose of vaccine are in no way comparable, and that considering them as a single group could lead to misleading conclusions. Nevertheless, that’s the hand that’s been dealt for us.
The data are somewhat surprising. While those given a booster dose of vaccine seem to have lower levels of hospitalisations than found in the group containing the unvaccinated and those given only one dose of vaccine – as might be expected – the double dosed have significantly higher hospitalisation rates.
Also interesting is the trend in the data:
Hospitalisations in the unvaccinated/single-dosed appear to peak earliest – we have also seen this effect in U.K. data, usually in the form of dire warnings early in each Covid wave that the only people being hospitalised are the unvaccinated, only for the warnings to go quiet later in the Covid wave when the data move in the opposite direction.
Hospitalisations in those given two doses of vaccine appear to peak towards the end of the period shown.
Hospitalisations in the boosted population appear to show little signs of slowing down, let alone reducing, over the period in question. Note also that this group saw a fourfold increase over the time period shown, whereas the double dose and single-dose/unvaccinated group both saw a 25% increase, albeit with an intermediate period with higher hospitalisation rates.
It was not possible to properly disentangle the hospitalisations data for the unvaccinated, but the data suggest that in aggregate those having taken two or three doses of vaccine (when the two groups are put together) have approximately 45% lower risk of hospitalisation than the unvaccinated/single-dosed. It is worth noting that in the U.K. data we see higher hospitalisation rates in the single vaccinated in those aged over 60, compared with the unvaccinated. It is possible that the same pattern is found in New Zealand, only ‘covered up’ by the co-mingling of the data. If this is the case then the apparent protection offered by the vaccine in the two or three dose individuals will be somewhat lower than 45%.
Deaths
The mortality data from New Zealand are also complicated because the health authorities lump together into one group all the unvaccinated and those having taken a single dose of vaccine. Beyond that complication, deaths data can be tricky to analyse, because there are such huge differences in death rates from (or with) Covid by age. Fortunately, the mortality data offered by the New Zealand authorities do include deaths by age group, which allows a finer analysis than was possible with the infections and hospitalisations data.
Covid mortality per 100,000 per week, by vaccination status and age
The above table suggests that while those given three doses of vaccine have a decreased risk of death from (or with) Covid compared with the mortality rate in the strange group called ‘unvaccinated or one dose’, the risk of death is greatest in those given two doses of vaccine.
However, it is possible that New Zealand’s data have a similar pattern to that seen in the U.K. (and elsewhere), where dose effects are complicated by the health of those given each vaccine, namely that those closest to death were spared a dose of vaccine, and thus concentrated deaths into the very small number left in the prior dose group. A comparison of the data for ‘unvaccinated or one dose’ with ‘two or three doses’ suggests that the vaccines do still protect against death, but only to a very low degree in younger age groups.
Covid mortality per 100,000 per week, by vaccination status and age
The data above support the use of vaccination to protect against death from (or with) Covid for those aged over 80. On the other hand, the mortality rate in those aged under 60 is very low, and the estimated vaccine effectiveness in protecting against death for those aged under 80 is only approximately 30% – once again, the real-world vaccine effectiveness estimate is rather low. It is also of note that these rather poor figures for the protection offered by the vaccines against mortality come from a country that started vaccination rather late (summer 2021) and where most of the population were only given their booster doses two to three months ago. These data suggest that the vaccines simply do not offer substantive protection against death for newer Covid variants, rather than it simply being a case of waning vaccine protection.
It is also important to note that the data on the benefits of the vaccine in protecting against death shown above should be treated with caution:
Data on deaths in the unvaccinated and those given a single dose of vaccine are co-mingled; the New Zealand hospitalisation data suggest that death rates might be greater in the single-jabbed.
The vaccinated appear to have significant increased risk of catching Covid, which contributes to overall risk of serious disease and death.
These calculations do not include any consideration of the risk of side-effects and complications following vaccination.
Overall mortality
One other aspect of the data coming from New Zealand that is of interest relating to Covid is excess mortality. These data are of interest because New Zealand managed to keep itself more-or-less clear of Covid until the last few months of 2021, and even then case numbers were very low until 2022, with the result that Covid deaths were negligible prior to 2022. With that in mind, its excess death data between the start of 2020 and the end of 2021 are very interesting.
Many countries around the world had a peak in excess deaths in the first quarter of 2020, followed by a significant reduction in deaths into mid 2020. There has been speculation that this pattern was seen because Covid infections in early 2020 killed the most vulnerable, leaving a period in which there were fewer people left to die. However, New Zealand also has this pattern of excess deaths in the first half of 2020 (black data points in the graph above) without Covid infections, suggesting that the reduction in deaths seen in mid 2020 were a result of lockdown. The reason for the excess deaths in New Zealand in the first quarter of 2020 are not at all clear.
Most countries then saw an increase in deaths towards the end of 2020; this has been explained by a resurgence in Covid cases. However, New Zealand saw a similar pattern without Covid infections (red data points). It is possible that this increase was caused by the impact of the reduced healthcare provision during the extreme lockdown – though there are no data to support this supposition. There are reports that the New Zealand healthcare system experienced its busiest summer (January and February) on record with hospitals across the country reaching ‘crisis point’ and several emergency departments at capacity. The cause of this healthcare pressure is unclear, however.
Perhaps the most interesting data in the graph above are seen in 2021. During the first half of 2021 excess deaths slowly reduced from the high seen at the start of 2021 (green data points), perhaps a result of healthcare provision returning to normal. However, around mid-year the trend reversed and excess deaths started to climb again (purple data points). Again, it must be pointed out that there were very few Covid cases in New Zealand at this time, and negligible deaths. Just about the only unusual things occurring in the country at that time were a lack of international travel, restrictions in day-to-day activities for the population and an enormous mass vaccination campaign using novel, under-tested vaccines.
During 2020-2022, there were approximately 2,000 excess deaths in New Zealand, a significant number in a country with a population of five million. We don’t know the proportion that occurred because of lockdown, vaccines or something else; all that we do know is that they weren’t a result of Covid.
Note on data analysis methods. Infection, hospitalisation and mortality data were obtained from the New Zealand Ministry for Health (using Wayback Machine for historical data). Vaccination data were also obtained from the NZ Ministry for Health. Population data were obtained from Stats.govt.nz. Vaccination data were offset by seven days for the infections analysis to account for the Ministry for Health’s definition of vaccine status at infection. An additional seven days offset was applied for hospitalisation, and 14 days for death, to account for the typical timescales of disease progression.
https://dailysceptic.org/2022/04/09/vaccinated-have-up-to-six-times-the-infection-rate-of-unvaccinated-new-zealand-government-data-show/?source=patrick.net
1557
richwicks
2022 Apr 9, 3:49pm
richwicks
2022 Apr 9, 3:49pm
Patrick says
This is quite possibly a reasonable person, not somebody pushing the vaccine on everybody.
This is quite possibly a reasonable person, not somebody pushing the vaccine on everybody.
1559
Shaman
2022 Apr 10, 8:52am
Shaman
2022 Apr 10, 8:52am
This chart is from the UK data and compiled by the gato malo substack person. It shows the ratio of risk of getting Covid when vaxxed/unvaxxed. The antigenic fixation appears to make one much more likely to get Covid when vaxxed and especially when boosted.
1560
Patrick
2022 Apr 11, 9:49am
https://www.gettr.com/post/p14kuw267ad?source=patrick.net
Patrick
2022 Apr 11, 9:49am
Arnie1974
@Arnie1974
·
19h
Australia:
Sunday Footy Show host ADMITS live on air - that Covid-19 booster shots are causing multiple players to suffer serious Heart Issues & Bells Palsy.
“Wards filled with people suffering the same issues”
Finally some truth coming out about the vaccines.
https://www.gettr.com/post/p14kuw267ad?source=patrick.net
1561
Patrick
2022 Apr 11, 5:28pm
Patrick
2022 Apr 11, 5:28pm
https://childrenshealthdefense.org/defender/exclusive-son-describes-mothers-death-moderna-shot/?source=patrick.net
Carol Beauchine died Aug. 2, 2021, from sporadic Creutzfeldt-Jakob Disease (CJD), a rapidly developing, fatal degenerative brain disorder she developed after her second dose of Moderna’s COVID-19 vaccine.
In an exclusive interview with The Defender, Carol’s son, Jeffrey Beauchine, said it was excruciating to watch his 70-year-old mother — who was healthy until she got the vaccine — die from a disease he believes the vaccine caused.
1562
Patrick
2022 Apr 12, 6:27pm
Patrick
2022 Apr 12, 6:27pm
https://markcrispinmiller.substack.com/p/in-memory-of-those-who-died-suddenly-cb1?s=r&source=patrick.net
https://markcrispinmiller.substack.com/p/in-memory-of-those-who-died-suddenly-f2e?s=r&source=patrick.net
https://markcrispinmiller.substack.com/p/in-memory-of-those-who-died-suddenly?s=r&source=patrick.net
https://markcrispinmiller.substack.com/p/in-memory-of-those-who-died-suddenly-637?s=r&source=patrick.net
https://markcrispinmiller.substack.com/p/in-memory-of-those-who-died-suddenly-f2e?s=r&source=patrick.net
https://markcrispinmiller.substack.com/p/in-memory-of-those-who-died-suddenly?s=r&source=patrick.net
https://markcrispinmiller.substack.com/p/in-memory-of-those-who-died-suddenly-637?s=r&source=patrick.net
1563
Ceffer
2022 Apr 13, 12:46am
Ceffer
2022 Apr 13, 12:46am
Vaxxed? Notice how they never mention it.
https://variety.com/2022/film/news/gilbert-gottfried-dead-dies-comedian-aladdin-1235231387/?source=patrick.net
https://variety.com/2022/film/news/gilbert-gottfried-dead-dies-comedian-aladdin-1235231387/?source=patrick.net
1565
Al_Sharpton_for_President
2022 Apr 13, 4:29am
Al_Sharpton_for_President
2022 Apr 13, 4:29am
Ceffer says
Vaxxed? Notice how they never mention it.V tach - bag of worms. The vax is known to be cardiotoxic. If you have a pre-existing heart condition...?
1566
Karloff
2022 Apr 13, 7:16am
Karloff
2022 Apr 13, 7:16am
Gottfried's death was apparently due to complications from muscular dystrophy. Did the shot amplify this somehow? We'll probably never know.
Dead after a coof diagnosis: Official coof death on the records. panic_level++
Dead after the shot: Nothing but a coincidence, you can't prove its linked, shut up anti-vaxxer.
Dead after a coof diagnosis: Official coof death on the records. panic_level++
Dead after the shot: Nothing but a coincidence, you can't prove its linked, shut up anti-vaxxer.
« First « Previous Comments 1,537 - 1,576 of 8,279 Next » Last » Search these comments
https://bigleaguepolitics.com/better-call-saul-star-bob-odenkirk-collapses-on-set-after-receiving-experimental-covid-19-vaccine/